Table of Contents
Volume 5 | Supplement 2
Publication Date: April 2004- Abstract
- No Access
- Pay-Per View
- Full Text
- Add to Cart
Introduction | ||
S45 |
Current Perspectives with Pemetrexed in Thoracic Malignancies Chandra P. Belani |
|
Contributions | ||
S46-S50 |
Pathogenesis of Malignant Mesothelioma Michele Carbone, Monica A. Rdzanek, Paul Setlak |
|
S51-S55 |
Pharmacology and Mechanism of Action of Pemetrexed Alex A. Adjei |
|
S56-S60 |
Pemetrexed Alone and in Combination with Platinum Compounds in the Management of Malignant Mesothelioma Harit Suwanrusme, Mario L. Meyer, Mark R. Green |
|
S61-S66 |
Novel Combinations Using Pemetrexed in Malignant Mesothelioma Shirish M. Gadgeel, Harvey I. Pass |
|
S67-S74 |
Pemetrexed in the Treatment of Advanced Non–Small-Cell Lung Cancer: A Review of the Clinical Data Ralph G. Zinner, Roy S. Herbst |
|
S75-S79 |
Second-Line Chemotherapy for Non–Small-Cell Lung Cancer: Recent Data with Pemetrexed Nasser H. Hanna |
|